|
1
|
Siegel RJ, Miller KD and Jemal A: Cancer
statistics, 2019. CA Cancer J Clin. 69:7–34. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
2
|
Bray F, Ferlay J, Soerjomataram I, Siegel
RL, Torre LA and Jemal A: Global cancer statistics 2018: GLOBOCAN
estimates of incidence and mortality worldwide for 36 cancers in
185 countries. CA Cancer J Clin. 68:394–424. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
3
|
Ferlay J, Colombet M, Soerjomataram I,
Mathers C, Parkin DM, Pineros M, Znaor A and Bray F: Estimating the
global cancer incidence and mortality in 2018: GLOBOCAN sources and
methods. Int J Cancer. 144:1941–1953. 2019. View Article : Google Scholar : PubMed/NCBI
|
|
4
|
Le Bras GF, Farooq MH, Falk GW and Andl
CD: Esophageal cancer: The latest on chemoprevention and state of
the art therapies. Pharmacol Res. 113A:A236–A244. 2016. View Article : Google Scholar : PubMed/NCBI
|
|
5
|
Zhao J, He YT, Zheng RS, Zhang SW and Chen
WQ: Analysis of esophageal cancer time trends in China, 1989-2008.
Asian Pac J Cancer Prev. 13:4613–4617. 2012. View Article : Google Scholar : PubMed/NCBI
|
|
6
|
Ohashi S, Miyamoto S, Kikuchi O, Goto T,
Amanuma Y and Muto M: Recent advances from basic and clinical
studies of esophageal squamous cell carcinoma. Gastroenterology.
149:1700–1715. 2015. View Article : Google Scholar : PubMed/NCBI
|
|
7
|
Liang H, Fan JH and Qiao YL: Epidemiology,
etiology, and prevention of esophageal squamous cell carcinoma in
China. Cancer Biol Med. 14:33–41. 2017. View Article : Google Scholar : PubMed/NCBI
|
|
8
|
van Rossum PSN, Mohammad NH, Vleggaar FP
and van Hillegersberg R: Treatment for unresectable or metastatic
oesophageal cancer: Current evidence and trends. Nat Rev
Gastroenterol Hepatol. 15:235–249. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
9
|
Dai T and Shah MA: Chemoradiation in
oesophageal cancer. Best Pract Res Clin Gastroenterol. 29:193–209.
2015. View Article : Google Scholar : PubMed/NCBI
|
|
10
|
Prevost M, Chamousset D, Nasa I, Freele E,
Morrice N, Moorhead G and Trinkle-Mulcahy L: Quantitative
fragmentome mapping reveals novel, domain-specific partners for the
modular protein RepoMan (recruits PP1 onto mitotic chromatin at
anaphase). Mol Cell Proteomics. 12:1468–1486. 2013. View Article : Google Scholar : PubMed/NCBI
|
|
11
|
Feng Y, Qian W, Zhang Y, Peng W, Li J, Gu
Q, Ji D, Zhang Z, Wang Q, Zhang D and Sun Y: CDCA2 promotes the
proliferation of colorectal cancer cells by activating the
AKT/CCND1 pathway in vitro and in vivo. BMC Cancer. 19:5762019.
View Article : Google Scholar : PubMed/NCBI
|
|
12
|
Uchida F, Uzawa K, Kasamatsu A, Takatori
H, Sakamoto Y, Ogawara K, Shiiba M, Bukawa H and Tanzawa H:
Overexpression of CDCA2 in human squamous cell carcinoma:
Correlation with prevention of G1 phase arrest and apoptosis. PLoS
One. 8:e563812013. View Article : Google Scholar : PubMed/NCBI
|
|
13
|
Shi R, Zhang C, Wu Y, Wang X, Sun Q, Sun
J, Xia W, Dong G, Wang A, Jiang F and Xu L: CDCA2 promotes lung
adenocarcinoma cell proliferation and predicts poor survival in
lung adenocarcinoma patients. Oncotarget. 8:19768–19779. 2017.
View Article : Google Scholar : PubMed/NCBI
|
|
14
|
Peng A, Lewellyn AL, Schiemann WP and
Maller JL: Repo-man controls a protein phosphatase 1-dependent
threshold for DNA damage checkpoint activation. Curr Biol.
20:387–396. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
15
|
Vagnarelli P: Repo-man at the intersection
of chromatin remodelling, DNA repair, nuclear envelope
organization, and cancer progression. Adv Exp Med Biol.
773:401–414. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
16
|
Livak KJ and Schmittgen TD: Analysis of
relative gene expression data using real-time quantitative PCR and
the 2(-Delta Delta C(T)) Method. Methods. 25:402–408. 2001.
View Article : Google Scholar : PubMed/NCBI
|
|
17
|
Zhao Y, Yi J, Tao L, Huang G, Chu X, Song
H and Chen L: Wnt signaling induces radioresistance through
upregulating HMGB1 in esophageal squamous cell carcinoma. Cell
Death Dis. 9:4332018. View Article : Google Scholar : PubMed/NCBI
|
|
18
|
Dillon MT, Good JS and Harrington KJ:
Selective targeting of the G2/M cell cycle checkpoint to improve
the therapeutic index of radiotherapy. Clin Oncol (R Coll Radiol).
26:257–265. 2014. View Article : Google Scholar : PubMed/NCBI
|
|
19
|
Sinclair WK and Morton RA: X-ray
sensitivity during the cell generation cycle of cultured Chinese
hamster cells. Radiat Res. 29:450–474. 1966. View Article : Google Scholar : PubMed/NCBI
|
|
20
|
Terasima T and Tolmach LJ: Variations in
several responses of HeLa cells to x-irradiation during the
division cycle. Biophys J. 3:11–33. 1963. View Article : Google Scholar : PubMed/NCBI
|
|
21
|
Pawlik TM and Keyomarsi K: Role of cell
cycle in mediating sensitivity to radiotherapy. Int J Radiat Oncol
Biol Phys. 59:928–942. 2004. View Article : Google Scholar : PubMed/NCBI
|
|
22
|
Zheng N, Zhang S, Wu W, Zhang N and Wang
J: Regulatory mechanisms and therapeutic targeting of vasculogenic
mimicry in hepatocellular carcinoma. Pharmacol Res. 166:1055072021.
View Article : Google Scholar : PubMed/NCBI
|
|
23
|
Petersen EV, Chudakova DA, Skorova EY,
Anikin V, Reshetov IV and Mynbaev OA: The extracellular
matrix-derived biomarkers for diagnosis, prognosis, and
personalized therapy of malignant tumors. Front Oncol.
10:5755692020. View Article : Google Scholar : PubMed/NCBI
|
|
24
|
Krasnoselsky AL, Whiteford CC, Wei JS,
Bilke S, Westermann F, Chen QR and Khan J: Altered expression of
cell cycle genes distinguishes aggressive neuroblastoma. Oncogene.
24:1533–1541. 2005. View Article : Google Scholar : PubMed/NCBI
|
|
25
|
Xiao B, Chen L, Ke Y, Hang J, Cao L, Zhang
R, Zhang W, Liao Y, Gao Y, Chen J, et al: Identification of
methylation sites and signature genes with prognostic value for
luminal breast cancer. BMC Cancer. 18:4052018. View Article : Google Scholar : PubMed/NCBI
|
|
26
|
Chang L, Graham PH, Hao J, Ni J, Bucci J,
Cozzi PJ, Kearsley JH and Li Y: PI3K/Akt/mTOR pathway inhibitors
enhance radiosensitivity in radioresistant prostate cancer cells
through inducing apoptosis, reducing autophagy, suppressing NHEJ
and HR repair pathways. Cell Death Dis. 5:e14372014. View Article : Google Scholar : PubMed/NCBI
|
|
27
|
He G, Di X, Yan J, Zhu C, Sun X and Zhang
S: Silencing human epidermal growth factor receptor-3
radiosensitizes human luminal A breast cancer cells. Cancer Sci.
109:3774–3782. 2018. View Article : Google Scholar : PubMed/NCBI
|
|
28
|
Buckley AM, Lynam-Lennon N, O'Neill H and
O'Sullivan J: Targeting hallmarks of cancer to enhance
radiosensitivity in gastrointestinal cancers. Nat Rev Gastroenterol
Hepatol. 17:298–313. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
29
|
Sadoughi F, Mirsafaei L, Dana PM,
Hallajzadeh J, Asemi Z, Mansournia MA, Montazer M, Hosseinpour M
and Yousefi B: The role of DNA damage response in chemo- and
radio-resistance of cancer cells: Can DDR inhibitors sole the
problem? DNA Repair (Amst). 101:1030742021. View Article : Google Scholar : PubMed/NCBI
|
|
30
|
Lynam-Lennon N, Reynolds JV, Pidgeon GP,
Lysaght J, Marignol L and Maher SG: Alterations in DNA repair
efficiency are involved in the radioresistance of esophageal
adenocarcinoma. Radiat Res. 174:703–711. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
31
|
Liu C, Gross N, Li Y, Li G, Wang Z, Zhong
S, Li Y and Hu G: PARP inhibitor Olaparib increases the
sensitization to radiotherapy in FaDu cells. J Cell Mol Med.
24:2444–2450. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
32
|
Sak A and Stuschke M: Use of gammaH2AX and
other biomarkers of double-strand breaks during radiotherapy. Semin
Radiat Oncol. 20:223–231. 2010. View Article : Google Scholar : PubMed/NCBI
|
|
33
|
Bouzinab K, Summers HS, Stevens MFG, Moody
CJ, Thomas NR, Gershkovich P, Weston N, Ashford MB, Bradshaw TD and
Turyanska L: Delivery of temozolomide and N3-propargyl analog to
brain tumors using an apoferritin nanocage. ACS Appl Mater
Interfaces. 12:12609–12617. 2020. View Article : Google Scholar : PubMed/NCBI
|
|
34
|
Maity A, McKenna WG and Muschel RJ: The
molecular basis for cell cycle delays following ionizing radiation:
A review. Radiother Oncol. 31:1–13. 1994. View Article : Google Scholar : PubMed/NCBI
|
